| Product Code: ETC7664570 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Veterinary Intravenous (IV) Solutions Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Veterinary Intravenous (IV) Solutions Market - Industry Life Cycle |
3.4 Israel Veterinary Intravenous (IV) Solutions Market - Porter's Five Forces |
3.5 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By Animal Type, 2021 & 2031F |
3.8 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Israel Veterinary Intravenous (IV) Solutions Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing adoption of advanced veterinary care practices in Israel |
4.2.2 Growing pet ownership and spending on pet healthcare |
4.2.3 Rising prevalence of chronic diseases in animals |
4.3 Market Restraints |
4.3.1 Stringent regulations related to veterinary medications and solutions |
4.3.2 Limited awareness and access to veterinary intravenous solutions in rural areas |
5 Israel Veterinary Intravenous (IV) Solutions Market Trends |
6 Israel Veterinary Intravenous (IV) Solutions Market, By Types |
6.1 Israel Veterinary Intravenous (IV) Solutions Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Isotonic crystalloids, 2021- 2031F |
6.1.4 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Synthetic colloids, 2021- 2031F |
6.1.5 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Blood products, 2021- 2031F |
6.1.6 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Dextrose solutions, 2021- 2031F |
6.1.7 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Parenteral nutrition, 2021- 2031F |
6.2 Israel Veterinary Intravenous (IV) Solutions Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Diabetic Ketoacidosis, 2021- 2031F |
6.2.3 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Pancreatitis, 2021- 2031F |
6.2.4 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Anthrax, 2021- 2031F |
6.2.5 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Chronic Kidney Disease, 2021- 2031F |
6.2.6 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Veterinary Intravenous (IV) Solutions Market, By Animal Type |
6.3.1 Overview and Analysis |
6.3.2 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Companion Animals, 2021- 2031F |
6.3.3 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Production Animals, 2021- 2031F |
6.4 Israel Veterinary Intravenous (IV) Solutions Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Veterinary Hospitals, 2021- 2031F |
6.4.3 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.4.4 Israel Veterinary Intravenous (IV) Solutions Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Veterinary Intravenous (IV) Solutions Market Import-Export Trade Statistics |
7.1 Israel Veterinary Intravenous (IV) Solutions Market Export to Major Countries |
7.2 Israel Veterinary Intravenous (IV) Solutions Market Imports from Major Countries |
8 Israel Veterinary Intravenous (IV) Solutions Market Key Performance Indicators |
8.1 Average revenue per veterinary clinic using intravenous solutions |
8.2 Number of veterinary clinics offering intravenous solutions |
8.3 Adoption rate of intravenous solutions in veterinary surgeries |
9 Israel Veterinary Intravenous (IV) Solutions Market - Opportunity Assessment |
9.1 Israel Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By Animal Type, 2021 & 2031F |
9.4 Israel Veterinary Intravenous (IV) Solutions Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Israel Veterinary Intravenous (IV) Solutions Market - Competitive Landscape |
10.1 Israel Veterinary Intravenous (IV) Solutions Market Revenue Share, By Companies, 2024 |
10.2 Israel Veterinary Intravenous (IV) Solutions Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here